Stock Information
Qiagen NV (QGEN)
Ticker Symbol: QGEN
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $8,931.62 mil
Piotroski score: 7
PE Ratio: 19.8664
EPS (TTM): 1.9963
Revenue (TTM): $9.57 M
Dividend Yield: 0.63198366954851%
ROE: 11.85%
Latest News
-
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
Thu, Apr 16, 2026 4:07 PM
-
Qiagen N : Sustainability Report (qiagen uk gender pay 2025 website v3)
Wed, Apr 15, 2026 9:40 AM
-
Barclays Downgrades Qiagen N.V. (QGEN)
Wed, Apr 15, 2026 12:04 AM
-
Qiagen N.V. Expands into Bloodstream Infection Syndromic Testing with New Rapid QIAstat-Dx Panel
Tue, Apr 14, 2026 4:50 PM
-
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
Tue, Apr 14, 2026 4:06 PM
-
Barclays Downgrades Qiagen to Equal-Weight, Announces $44 Price Target
Tue, Apr 14, 2026 9:18 AM
-
QIAGEN NV : Barclays is less optimistic
Tue, Apr 14, 2026 7:46 AM
Key Financials
Financial data not available
